Canada Life
MNTA

Canada Life’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Canada Life’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-143,914
Closed -$4.78M – 2748
2020
Q2 		$4.78M Sell
143,914
-5,317
-4% -$169K 0.01% 700
2020
Q1 		$4.06M Buy
149,231
+9,945
+7% +$277K 0.01% 695
2019
Q4 		$2.72M Buy
+139,286
New +$2.23M 0.01% 957
2019
Q3 		– Sell
-130,750
Closed -$1.63M – 2635
2019
Q2 		$1.63M Hold
130,750
– – ﹤0.01% 1290
2019
Q1 		$1.9M Buy
130,750
+3,437
+3% +$43.9K 0.01% 1083
2018
Q4 		$1.29M Buy
127,313
+30,353
+31% +$422K ﹤0.01% 1276
2018
Q3 		$2.54M Hold
96,960
– – 0.01% 1007
2018
Q2 		$1.98M Sell
96,960
-1,011
-1% -$21.7K ﹤0.01% 1188
2018
Q1 		$1.77M Hold
97,971
– – ﹤0.01% 1222
2017
Q4 		$1.37M Sell
97,971
-4,000
-4% -$54.1K ﹤0.01% 1387
2017
Q3 		$1.94M Buy
101,971
+5,500
+6% +$91.9K ﹤0.01% 1175
2017
Q2 		$1.63M Buy
96,471
+7,450
+8% +$113K ﹤0.01% 1285
2017
Q1 		$1.18M Buy
89,021
+4,936
+6% +$77.3K ﹤0.01% 1437
2016
Q4 		$1.27M Hold
84,085
– – ﹤0.01% 1381
2016
Q3 		$982K Buy
84,085
+3,179
+4% +$37.4K ﹤0.01% 1455
2016
Q2 		$872K Buy
80,906
+74,168
+1,101% +$765K ﹤0.01% 1473
2016
Q1 		$62K Hold
6,738
– – ﹤0.01% 2041
2015
Q4 		$100K Hold
6,738
– – ﹤0.01% 1764
2015
Q3 		$111K Hold
6,738
– – ﹤0.01% 1628
2015
Q2 		$153K Buy
6,738
+4,800
+248% +$95.6K ﹤0.01% 1546
2015
Q1 		$29K Hold
1,938
– – ﹤0.01% 2265
2014
Q4 		$23K Hold
1,938
– – ﹤0.01% 2312
2014
Q3 		$22K Hold
1,938
– – ﹤0.01% 2301
2014
Q2 		$23K Hold
1,938
– – ﹤0.01% 2215
2014
Q1 		$22K Hold
1,938
– – ﹤0.01% 2114
2013
Q4 		$34K Buy
+1,938
New +$32.6K ﹤0.01% 1994

Other funds holding MNTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

Canada Life's MNTA Position: Q3 2020 in Review

Canada Life sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 143,914 shares — an estimated $4.78M sold.

Canada Life first reported a position in MNTA in Q4 2013 and held it in 26 quarters. The position peaked at $4.78M in Q2 2020. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

  • Canada Life reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Canada Life sold 143,914 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $4.78M.
  • Canada Life first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2013 and held it in 26 quarters.
  • Canada Life's Momenta Pharmaceuticals, Inc. position peaked at $4.78M in Q2 2020.
  • 211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on Canada Life's 13F filing for Q3 2020, filed 13 Nov 2020.